Business Context and Reporting Period
SeaStar Medical Holding Corp (ICU) filed a Form 8-K on December 18, 2025, reporting the results of a special meeting of shareholders held on the same date. The company, incorporated in Delaware and listed on the Nasdaq Capital Market, is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
Shareholders approved three material proposals at the special meeting:
- Reverse Stock Split: A 1-for-10 reverse stock split was approved. It will become effective at 12:01 AM EST on January 2, 2026. Post-split, approximately 3.8 million shares of common stock will be outstanding. Outstanding options and warrants will be proportionally adjusted.
- Authorized Share Reduction: The number of authorized common shares was reduced by 25,000,000 to 425,000,000.
- Adjournment Proposal: Shareholders approved a proposal to adjourn the meeting if necessary to solicit further votes.
Voting results for the Reverse Stock Split Proposal were 16,454,058 votes for, 5,600,251 against, and 124,514 abstentions.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future operations, or specific risk factors beyond the standard disclosure of the reverse split mechanics. The company noted that fractional shares will not be issued; instead, share counts will be rounded up to the next whole number.
Investor Verification Checklist
- Verify the effective date of the reverse split (January 2, 2026) and the adjusted trading symbol (ICU).
- Confirm the adjusted number of outstanding shares (approximately 3.8 million) and the impact on existing option and warrant holdings.
- Review the new authorized share count of 425,000,000.
- Check with brokerage firms regarding the automatic adjustment of positions held in nominee accounts.